23andMe (ME) - 2023 Q3 - Earnings Call Transcript

23andMe Holding Co. (NASDAQ:ME) Q3 2022 Earnings Conference Call February 8, 2023 4:30 PM ET Company Participants Wade Walke - VP, Investor Relations Anne Wojcicki - CEO & Co-Founder Joe Selsavage - Interim CFO & Accounting Officer Kenneth Hillan - Chief Therapeutics Officer Conference Call Participants Daniel Grosslight - Citigroup Steven Mah - Cowen Gaurav Goparaju - Berenberg Operator Good day, and welcome to 23andMe's Fiscal Year 2023 Third Quarter Financial Results Conference Call. At a reminder, this ...